Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biohaven Ltd (NY: BHVN ) 50.88 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biohaven Ltd < Previous 1 2 3 4 5 6 7 8 Next > Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday October 11, 2022 Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 10, 2022 Gainers Via Benzinga Recap: Biohaven Pharma Hldgs Q2 Earnings August 05, 2022 Biohaven Pharma Hldgs (NYSE:BHVN) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Coinbase Global And 3 Other Stocks Insiders Are Buying October 07, 2022 Although US stocks closed lower on Thursday, there were a few notable insider trades. Via Benzinga Biohaven Ltd. Surges 7.6%: Is This An Indication Of Further Gains? October 07, 2022 Biohaven Ltd. shares ended the last trading session 7.6% higher at $13.18. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares... Via Talk Markets Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session October 06, 2022 U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving Premarket October 06, 2022 Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 89.4% to $0.2655 in pre-market trading. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For... Via Benzinga Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday October 06, 2022 Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 04, 2022 On Tuesday, 44 companies hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 04, 2022 Gainers Avenue Therapeutics (NASDAQ:ATXI) shares moved upwards by 37.7% to $15.85 during Tuesday's pre-market session. The company's market cap stands at $23.3 million. Via Benzinga Pfizer Completes Acquisition of Biohaven Pharmaceuticals October 03, 2022 From Pfizer Inc. Via Business Wire IPO Scorcher Amylyx Wins FDA Approval In ALS Treatment, Ending A Long Battle September 29, 2022 The drug has faced two advisory committees and a delayed review date. Via Investor's Business Daily Biohaven's ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months September 29, 2022 Biohaven Pharmaceutical Holding Company Ltd (NASDAQ: BHVN) announced results from a focused analysis of verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS). Via Benzinga Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test September 29, 2022 Patients didn't show any improvements in a study meant to test multiple drugs. Via Investor's Business Daily Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Rise Above Previous 52-Week High September 27, 2022 Via Investor Brand Network Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Exceed 52-Week High September 26, 2022 Via Investor Brand Network Stocks That Hit 52-Week Highs On Friday September 23, 2022 On Friday, 5 companies hit new 52-week highs. Via Benzinga Watch for Continued Gains in Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) September 23, 2022 Via Investor Brand Network Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin September 15, 2022 The market is struggling, yet biotech stocks are acting like it's good times again. Here's why. Via Investor's Business Daily Is Viatris Inc. a Contrarian Dividend Option for Your Portfolio? September 03, 2022 Does kicking against market trends make you even more excited about investing? If so, you may want to consider drugmaker Viatris Inc. (NASDAQ: VTRS), which produces products that treat diabetes,... Via MarketBeat Biohaven Pharmaceutical's Return On Capital Employed Overview August 26, 2022 Benzinga Pro data, Biohaven Pharmaceutical (NYSE:BHVN) reported Q2 sales of $215.08 million. Earnings fell to a loss of $441.88 million, resulting in a 278.01% decrease from last quarter. Via Benzinga $5.6 Million Bet On This Healthcare Stock? 3 Stocks Insiders Are Buying August 23, 2022 Although US stocks closed sharply lower on Monday, there were a few notable insider trades. Via Benzinga Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know August 23, 2022 Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022 August 19, 2022 Upgrades Via Benzinga Why These Pfizer Analysts Like The Global Blood Therapeutics Deal August 08, 2022 Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT). Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 August 08, 2022 Via Benzinga Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion August 05, 2022 Shares of Pfizer's rumored takeover target have rocketed for two days running. Via Investor's Business Daily The 3 Best Market Sectors for the Second Half of 2022 July 27, 2022 Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into. Via InvestorPlace Which Coronavirus Stock Could Fetch Higher Returns? July 11, 2022 This article will compare Pfizer, Moderna, and Novavax to see which of these coronavirus stocks will yield the highest returns. Via InvestorPlace Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven’s Troriluzole and Vigeo’S VT1021 in GBM AGILE Trial July 06, 2022 From Global Coalition for Adaptive Research Via Business Wire < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
